2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …

JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

[PDF][PDF] Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

B Williams, G Mancia, W Spiering, E Agabiti Rosei… - Rev Esp …, 2019 - peroxfarma.com
La tarea de elaboración de GPC incluye la creación de herramientas educativas y
programas de implementación de las recomendaciones. Para su implementación, se …

The pocketome of G-protein-coupled receptors reveals previously untargeted allosteric sites

JB Hedderich, M Persechino, K Becker… - Nature …, 2022 - nature.com
G-protein-coupled receptors do not only feature the orthosteric pockets, where most
endogenous agonists bind, but also a multitude of other allosteric pockets that have come …

2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - … of Hypertension of …, 2019 - taylorfrancis.com
Guidelines summarize and evaluate available evidence with the aim of assisting health
professionals in selecting the best management strategies for an individual patient with a …

Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients

GF Romiti, B Corica, E Pipitone, M Vitolo… - European Heart …, 2021 - academic.oup.com
Aim Prevalence of chronic obstructive pulmonary disease (COPD) in atrial fibrillation (AF)
patients is unclear, and its association with adverse outcomes is often overlooked. Our aim …

Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review

V Balbirsingh, AS Mohammed, AM Turner… - Thorax, 2022 - thorax.bmj.com
Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
cardiovascular disease (CVD) and concomitant disease leads to reduced quality of life …

[HTML][HTML] COPD and cardiovascular disease

S André, B Conde, E Fragoso, JP Boléo-Tomé… - Pulmonology, 2019 - Elsevier
COPD is one of the major public health problems in people aged 40 years or above. It is
currently the 4th leading cause of death in the world and projected to be the 3rd leading …

What can we learn from pulmonary function testing in heart failure?

H Magnussen, M Canepa, PE Zambito… - European Journal of …, 2017 - Wiley Online Library
Pulmonary diseases frequently coexist in heart failure (HF), thus posing diagnostic and
therapeutic challenges to cardiologists evaluating patients with overlapping symptoms and …

Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial …

A Chen, C Ju, IS Mackenzie, TM MacDonald… - The Lancet Regional …, 2023 - thelancet.com
Background There is no real-world evidence regarding the association between beta-
blocker use and mortality or cardiovascular outcomes in patients with obstructive sleep …